Search

everythinglearnresearchcommunity

for

Search:↓

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Tufted folliculitis is common in patients with folliculitis decalvans.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

FAPD is a possible diagnosis for hair loss in patients of color and requires multiple evaluations for accurate diagnosis.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

FFA and FAPD might be related or stages of the same disease.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Different types of hair loss have unique features under a microscope, but a doctor's exam is important for accurate diagnosis.

Scalp biopsy helps tell apart permanent and temporary hair loss types and guides treatment.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Cicatricial alopecia involves scarring hair loss and can be treated with various medications.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Reflectance confocal microscopy is a promising non-invasive tool for diagnosing alopecia areata incognita.

SOX10 in hair follicles is linked to inflammation in alopecia areata.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.